Curio Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Curio Pharmaceuticals
Curio Pharmaceuticals Private Limited (CPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 November 2020 (Four years and two months 13 days old ). Its registered office is in Cuddalore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Manimegalai and Ramakrishnan serve as directors at the Company.
Company Details
-
Location
Cuddalore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290PY2020PTC008635
-
Company No.
008635
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pondicherry
Industry
Who are the key members and board of directors at Curio Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manimegalai
|
Director | 20-Nov-2020 | Current |
|
Ramakrishnan
|
Director | 20-Nov-2020 | Current |
Financial Performance of Curio Pharmaceuticals.
Enhance accessibility to Curio Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curio Pharmaceuticals?
Unlock access to Curio Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Firstmed Therapeutics Private LimitedManimegalai and Ramakrishnan are mutual person
-
Zeta Formulation Private Limited
Ramakrishnan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curio Pharmaceuticals?
Unlock and access historical data on people associated with Curio Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curio Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.